Janssen Korea President takes aims Korea's top drug maker

Choi Tae-hong, president of Janssen Korea, said he will aggressively revamp the company's human resources in order to make the company one of Korea's leading pharmaceutical companies in terms of revenue, profit and shareholder return.

For this year, Choi is aiming for 200 billion won, up 11.2% last year. He also said he will increase research and development spending on local clinical trials...